Approximately 20% of women with advanced-stage ovarian cancer survive beyond 12 years after treatment and are effectively cured. Initial therapy for ovarian cancer comprises surgery and chemotherapy, and is given with the goal of eradicating as many cancer cells as possible. Indeed, the three ...
Travis Sims, MD, MPH, discusses the impact of homologous recombination deficiency status of clinical and survival outcomes in patients with advanced-stage ovarian cancer. Travis Sims, MD, MPH, a fellow in Gynecologic Oncology at The University of Texas MD Anderson Cancer Center, discusses the ...
Approximately 20% of women with advanced-stage ovarian cancer survive beyond 12 years after treatment and are effectively cured. Initial therapy for ovarian cancer comprises surgery and chemotherapy, and is given with the goal of eradicating as many cancer cells as possible. Indeed, the three phases...
Matthew Hadfield, DO, discusses his passion for early-stage clinical trials and the need for more research into immunotherapy toxicities during the third episode of Emerging Experts. Listen TORL-1-23 Well Tolerated in CLDN6+ Solid Tumors, Including Platinum-Resistant Ovarian Cancer ...
stage ovarian cancer: 1) referral to an expert center, with a rate of optimal primary cytoreduction of 75% and utilization of combined intraperitoneal and intravenous adjuvant chemotherapy, and 2) referral to a less experienced center, with a rate of optimal primary cytoreduction of 25% and ...
Currently, women are surviving longer with advanced ovarian cancer and treatment aims to improve quality of life along with increasing survival.doi:10.1007/978-1-4614-8271-0_10Butler, JohnLawrence, AlexandraSpringer USButler, J. & Lawrence, A. (2014). Treatment of advanced stage ovarian cancer....
Surgery, radiotherapy, and chemotherapy can each palliate advanced ovarian cancer. A combination of these needs assessment. Sixty patients with pelvic or abdominal dissemination received postoperative irradiation. Fifteen Stage II and 19 Stage III patients having more than half the tumor excised and no...
METHODS: A retrospective cohort study of consecutive patients with International Federation of Gynecology and Obstetrics stage IIIC ovarian cancer undergoing primary surgery was conducted between January 1, 1994, and December 31, 1998. The main outcome measures were residual disease after cytoreduction, ...
Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centr... Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centr...
BACKGROUND: Primary debulking surgery before initiation of chemotherapy has been the standard of care for patients with advanced ovarian cancer. METHODS: W... R Naik,DP Barton - 《N Engl J Med》 被引量: 1924发表: 2010年 Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovar...